Alert: Rating Upgrade (3/28/25)-Wave Life Sciences Ltd (NASDAQ: WVE).

out_logo_500#72735.jpg

Stock Rating Upgrade

Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Wave Life Sciences Ltd (NASDAQ: WVE) improved in the last week. WVE’s current Value Trend Rating is C and the prior Rating was D. Details supporting this higher rating are included in our next report.

out_mm#72735.jpg

Recent Price Action

Wave Life Sciences Ltd (NASDAQ: WVE) stock declined by -4.3% on 3/28/25. The shares closed at $8.62. Moreover, trading volume in this decline was above average at 120% of normal. The stock has declined -10.9% during the last week but has been exceptionally strong relative to the market over the last nine months.

Current PriceTarget Research Rating

Wave Life Sciences has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Wave Life Sciences has a very low Appreciation Score of 6 but a good Power Rating of 84, triggering the Low Neutral Value Trend Rating.

Be the first to comment

Leave a Reply

Your email address will not be published.


*